Karen E. Hoffman

The University of Texas MD Anderson Cancer Center

Papers

4

Total Citations

111

H-Index

4

About

Dr. Karen E. Hoffman is a leading health services researcher whose work focuses on improving outcomes for men with prostate cancer, particularly by comparing the real-world harms and benefits of different treatment modalities. Her landmark 2015 study, cited over 60 times, used population-based data to critically examine the comparative harms of open versus robotic prostatectomy, providing crucial evidence that challenged assumptions of robotic superiority. Dr. Hoffman’s prospective cohort research has further illuminated how treatments like brachytherapy and robot-assisted surgery impact patient quality of life, helping men make more informed decisions. She has also advanced the field by clarifying how to interpret domain scores on the widely-used EPIC-26 questionnaire, translating complex data into understandable functional outcomes for patients and clinicians. Through her work with the CEASAR study, Dr. Hoffman has assessed and defined quality measures for surgical care, ensuring that clinical practice is grounded in meaningful, patient-centered evidence. Her contributions are essential for guiding treatment choices and improving the standard of care in prostate cancer.

Research Focus

Key Achievements

4
H-Index
4
Papers
111
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples
64 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 48
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago